Pankajini Mallick
Pankajini Mallick
Neurocrine Biosciences
Verified email at
Cited by
Cited by
Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: Implications for biologics–small molecule drug interactions
P Mallick, G Taneja, B Moorthy, R Ghose
Expert opinion on drug metabolism & toxicology 13 (6), 605-616, 2017
The evolving druggability and developability space: chemically modified new modalities and emerging small molecules
W Yang, P Gadgil, VR Krishnamurthy, M Landis, P Mallick, D Patel, ...
The AAPS Journal 22, 1-14, 2020
Development and application of a life-stage physiologically based pharmacokinetic (PBPK) model to the assessment of internal dose of pyrethroids in humans
P Mallick, M Moreau, G Song, AY Efremenko, SN Pendse, MR Creek, ...
Toxicological Sciences 173 (1), 86-99, 2020
Population life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling
SN Pendse, A Efremenko, CE Hack, M Moreau, P Mallick, M Dzierlenga, ...
Computational Toxicology 13, 100115, 2020
Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures
ME Andersen, P Mallick, HJ Clewell III, M Yoon, GW Olsen, ...
Environmental research 197, 111183, 2021
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study
MW Dzierlenga, M Moreau, G Song, P Mallick, PL Ward, JL Campbell, ...
Environmental research 182, 109017, 2020
In vitro approaches to study regulation of hepatic cytochrome P450 (CYP) 3A expression by paclitaxel and rifampicin
R Ghose, P Mallick, G Taneja, C Chu, B Moorthy
Cancer Drug Resistance: Overviews and Methods, 55-68, 2016
Impact of diet on irinotecan toxicity in mice
P Mallick, P Shah, MM Ittmann, M Trivedi, M Hu, S Gao, R Ghose
Chemico-Biological Interactions 291, 87-94, 2018
Considerations for improving metabolism predictions for in vitro to in vivo extrapolation
M Moreau, P Mallick, M Smeltz, S Haider, CI Nicolas, SN Pendse, ...
Frontiers in Toxicology 4, 894569, 2022
Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro
P Mallick, S Basu, B Moorthy, R Ghose
Toxicology in Vitro 41, 75-82, 2017
Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicology
MB Black, A Stern, A Efremenko, P Mallick, M Moreau, JK Hartman, ...
Toxicology in Vitro 80, 105311, 2022
Physiologically based pharmacokinetic modeling in risk assessment: case study with pyrethroids
P Mallick, G Song, AY Efremenko, SN Pendse, MR Creek, TG Osimitz, ...
Toxicological Sciences 176 (2), 460-469, 2020
Utilizing in vitro transporter data in IVIVE-PBPK: an overview
P Mallick
ADMET and DMPK 5 (4), 201-211, 2017
Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats
K Varanasi, S Potharaju, S Rajak, S Veeraraghavan, P Mallick, ...
Methods Find Exp Clin Pharmacol 30 (7), 537-542, 2008
Effect of Pentoxifylline on the Pharmacokinetics of Nateglinide in Wistar Rat
KVS Varanasi, SR Suresh Potharaju, S Veerraghavan, SPN Sivakumar, ...
The Pharma professionals 1, 20-26, 2011
Role of Bacterial Translocation in the Progressive and Delayed Irinotecan-Induced Diarrhea
BK Kee, S Gao, PK Chityala, SR Yu He
J Clin Exp Pathol 8 (351), 2161-0681.1000351, 2018
Effect of Cilostazol on Pharmacokinetics of Nateglinide in Wistar Rats
P Mallick, SPN Sivakumar, SK VVS
The Pharma Professionals 1 (2), 2011
The system can't perform the operation now. Try again later.
Articles 1–18